Molecular genetics of prostate cancer: new prospects for old challenges

Michael M Shen1, Cory Abate-Shen

  • 1Department of Medicine, Columbia University Medical Center, New York, New York 10032, USA. mshen@columbia.edu

Genes & Development
|September 17, 2010
PubMed

Insights

Prostate cancer remains a significant health concern. Research is advancing our understanding of its progression, including castration resistance and stem cell roles, to develop new treatments.

Area of Science:

  • Oncology
  • Urology
  • Cancer Biology

Background:

  • Prostate cancer is a leading cause of cancer mortality in men.
  • Androgen deprivation therapy has been a cornerstone treatment since the 1940s.
  • Intensive research focuses on understanding prostate cancer initiation and progression.

Purpose of the Study:

  • To provide an overview of major themes in prostate cancer research.
  • To highlight recent advances in understanding cancer mechanisms.
  • To discuss potential therapeutic targets.

Main Methods:

  • Review of current knowledge on prostate cancer initiation and progression.
  • Discussion of recent research findings.
  • Focus on mechanisms of castration resistance and stem cell identification.

Main Results:

  • Significant progress has been made in understanding prostate cancer.
  • New insights into castration resistance mechanisms have emerged.
  • Development of mouse models aids preclinical evaluation of therapies.

Conclusions:

  • Prostate cancer research has seen tremendous progress.
  • Challenges remain in fully understanding and treating the disease.
  • Continued research is crucial for developing novel therapeutics.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...